Menu
Back to Dove Press podcast topics » International Journal of Chronic Obstructive Pulmonary Disease » International Journal of COPD podcast series » The importance of study design: The KEY to interpreting COPD research
The importance of study design: The KEY to interpreting COPD research
Join Dr Richard Russell and Professor Samy Suissa for the first episode of Season 4, as they discuss the importance of study design in the interpretation of COPD clinical trials.1,2 Listen as the experts examine the outcomes of well-known triple therapy studies and the consequences they may have for clinical practice.3,4 Dr Russell will also share highlights from a recent publication on the impact of best practice tariffs on COPD outcomes,5 before sharing this week’s social media hot topic of pulse oximeters and how patients can use them effectively.
1 Suissa S. COPD 2021;18:485–492;
2 Suissa S. COPD 2021; https://doi.org/10.1080/15412555.2021.1982886;
3 Lipson DA, et al. N Engl J Med 2018;378:1671–1680;
4 Rabe KF, et al. N Engl J Med 2020;383:35–48;
5 Stone PW, et al. Thorax 2022;77:239–246.
Disclosures
Professor Samy Suissa
In the last 3 years, Professor Suissa has attended scientific advisory committee meetings for Atara, Merck, Panalgo, Pfizer and Seqirus, and has received speaking fees from Boehringer Ingelheim and Novartis. Previously, he received research grants from Boehringer Ingelheim and Novartis.
Bios:
 |
Professor Samy Suissa Professor Suissa is a Distinguished James McGill Professor of Epidemiology and Biostatistics at McGill University, Canada, and Director of the Centre for Clinical Epidemiology, Lady Davis Institute of the Jewish General Hospital, Montreal, Canada. He heads the Canadian Network for Observational Drug Effect Studies. Professor Suissa has conducted extensive research on the real-world effects of medications for different chronic diseases, including asthma, COPD and idiopathic pulmonary fibrosis. He specialises in research methods, has authored over 550 peer-reviewed papers and serves on the editorial boards of various scientific journals. He is a fellow of the Royal Society of Canada and of the Canadian Academy of Health Science. He has received the Distinguished Investigator award from the Canadian Institutes of Health Research and the FC Donders Professorship award from University of Utrecht, Netherlands. |
This series of podcasts are intended for healthcare professionals only.
The Medical Insider COPD podcast series discusses hot topics in the world of COPD with those who know it best, aiming to spread information, debunk myths and improve the lives of patients. The Editorial Board of the Medical Insider COPD podcast is comprised of Professor James Chalmers, the British Lung Foundation Chair of Respiratory Research at the University of Dundee (UK), Professor Michael Dreher, the Head of the Department of Pneumology and Intensive Care Medicine at the University Hospital Aachen (Germany), and the host and moderator, Dr Richard Russell, a Consultant Chest Physician at Lymington New Forest Hospital (UK), a Senior Clinical Researcher at the University of Oxford (UK) and the founding editor of the International Journal of COPD. These series of podcasts have not been peer-reviewed, but have been vetted by the journal’s Editor-in-Chief.
Copyright © 2021, Boehringer Ingelheim Group of Companies. All rights reserved.
Publish time: 23 March 2022
Episode number: 10
Duration: 19 minutes 52 seconds